BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8593205)

  • 1. Analysis of nm23 expression as a prognostic parameter in renal cell carcinoma.
    Park DS; Cho NH; Lee YT; Park C; Lee JM
    J Korean Med Sci; 1995 Aug; 10(4):258-62. PubMed ID: 8593205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma.
    Srivatsa PJ; Cliby WA; Keeney GL; Dodson MK; Suman VJ; Roche PC; Podratz KC
    Gynecol Oncol; 1996 Mar; 60(3):363-72. PubMed ID: 8774640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoreactivity of nm23-H1 protein in renal cell carcinoma.
    Kuo JY; Chang KM; Chen KK; Chang LS
    Anticancer Res; 1998; 18(1B):531-6. PubMed ID: 9568173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of nm23 protein expression in renal cell carcinomas.
    Nakagawa Y; Tsumatani K; Kurumatani N; Cho M; Kitahori Y; Konishi N; Ozono S; Okajima E; Hirao Y; Hiasa Y
    Oncology; 1998; 55(4):370-6. PubMed ID: 9663430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of NM23 protein immunoreactivity in renal cell carcinoma using an image analyzer.
    Urakami S; Igawa M; Shirakawa H; Shiina H; Kawanishi M
    J Urol; 1997 May; 157(5):1928-31. PubMed ID: 9112565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. nm23 protein expression in renal cell tumors: the role of the cell type.
    Ayhan A; Usubütün A; Ozen H; Yasui W; Tahara E
    Oncol Rep; 1998; 5(4):979-83. PubMed ID: 9625858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
    Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
    Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of p53 and NDP-K/nm23 in gastric carcinomas--association with metastasis and clinicopathologic parameters.
    Kim KM; Lee A; Chae HS; Shim SI
    J Korean Med Sci; 1995 Dec; 10(6):406-13. PubMed ID: 8924224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of nm23/nucleoside diphosphate kinase-A protein in endometrial carcinoma.
    Srivatsa PJ; Cliby WA; Keeney GL; Suman VJ; Harmsen WS; Ziesmer SC; Roche PC; Podratz KC
    Gynecol Oncol; 1997 Aug; 66(2):238-45. PubMed ID: 9264569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. nm23-H1 protein immunoreactivity in laryngeal carcinoma.
    Lee CS; Redshaw A; Boag G
    Cancer; 1996 Jun; 77(11):2246-50. PubMed ID: 8635091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
    Shiina H; Igawa M; Nagami H; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T; Kawanishi M
    Cancer; 1996 Oct; 78(8):1762-74. PubMed ID: 8859190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladder.
    Alderisio M; Cenci M; Valli C; Russo A; Bazan V; Dardanoni G; Cucciarre S; Carreca I; Macaluso MP; Tomasino RM; Vecchione A
    Anticancer Res; 1998; 18(6A):4225-30. PubMed ID: 9891471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. nm23 protein expression in fine-needle aspirates from breast carcinoma: inverse correlation with cytologic grading, lymph node status, and ploidy.
    Sauer T; Furu I; Beraki K; Jebsen PW; Ormerod E; Naess O
    Cancer; 1998 Apr; 84(2):109-14. PubMed ID: 9570214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of nm23 in cell lines derived from patients with metastatic renal cell carcinoma.
    Walther MM; Anglard P; Gnarra J; Pozzatti R; Venzon D; de la Rosa A; MacDonald NJ; Steeg PS; Linehan WM
    J Urol; 1995 Jul; 154(1):278-82. PubMed ID: 7776445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of Nm23/NDPK expression in breast carcinoma, assessed on 10-year follow-up by automated and quantitative immunocytochemical assays.
    Charpin C; Garcia S; Bonnier P; Martini F; Andrac L; Horschowski N; Lavaut MN; Allasia C
    J Pathol; 1998 Apr; 184(4):401-7. PubMed ID: 9664906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of nm23 expression in renal cell carcinoma.
    Ljungberg B; Osterdahl B; Mehle C
    Urol Res; 1999 Apr; 27(2):103-7. PubMed ID: 10424391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between nm23-H1 expression and lymph node metastasis and prognosis in cervical cancer].
    Huang Y; Cai S; Yu S
    Zhonghua Fu Chan Ke Za Zhi; 1997 Dec; 32(12):718-21. PubMed ID: 9772433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of nm23-H1 in transitional cell carcinoma of the upper urinary tract.
    Cheng HL; Tong YC; Tzai TS; Weng CL; Ho CL; Yang WH; Lin JS; Chow NH
    Oncol Rep; 2001; 8(1):193-6. PubMed ID: 11115597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between nm23, angiogenesis, and the metastatic proclivity of node-negative breast cancer.
    Heimann R; Ferguson DJ; Hellman S
    Cancer Res; 1998 Jul; 58(13):2766-71. PubMed ID: 9661889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [nm23 gene product/NDPK expression and its clinical significance in human colorectal carcinoma].
    Wang C; Zhang X; Yang F
    Zhonghua Bing Li Xue Za Zhi; 1995 Dec; 24(6):356-8. PubMed ID: 8732091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.